Evidence map›Paper›PMID 26099633›Full record

ArticleJournal of ethnopharmacology2015

Developing an activity and absorption-based quality control platform for Chinese traditional medicine: Application to Zeng-Sheng-Ping(Antitumor B).

Taijun Yin, Guanyi Yang, Yong Ma, Beibei Xu, Ming Hu, Ming You, Song Gao

Registry-linked trialAbstract read
In one paragraph

Article in Journal of ethnopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04230057 (Pharmacokinetics Study of Antitumor B in Healthy Volunteers), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04230057 unknown statusnot on this mapstarted 2019, after this paper: background citation

Pharmacokinetics Study of Antitumor B in Healthy Volunteers

TypeobservationalSponsorUniversity of HoustonRan2019 to 2021Enrolled12ConditionsHealthy AdultsArmsAntitumor B
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Taijun YinDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX 77030, USA.
Guanyi YangHubei University of University affiliated Taihe Hospital, 30 South Renmin Road, Shiyan, Hubei, China.
Yong MaDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX 77030, USA.
Beibei XuDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX 77030, USA.
Ming HuDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX 77030, USA; Hubei University of University affiliated Taihe Hospital, 30 South Renmin Road, Shiyan, Hubei, China.
Ming YouMedical College of Wisconsin Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
Song GaoDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX 77030, USA; Hubei University of University affiliated Taihe Hospital, 30 South Renmin Road, Shiyan, Hubei, China. Electronic address: sgao3@uh.edu.
Hubei University · CNUniversity of Houston · USMedical College of Wisconsin · US

Funding

Chemoprevention of Lung Cancer with Anti-tumor BR01AT003203 · NCCIH · WASHINGTON UNIVERSITY · PI YOU, MING · 2007 to 2010
$1.5M
NCCIH NIH HHS AT003203NCCIH NIH HHS R01 AT003203
6 · The paper itself

Abstract

ethnopharmacological relevanceZeng-Sheng-Ping (ZSP), also called antitumor B, is a marketed Chinese traditional medicine used for cancer prevention. AIM OF THE STUDY: Currently, for the quality control of Chinese traditional medicines, marker compounds are not selected based on bioactivities and pharmaceutical behaviors in most of the cases. Therefore, even if the "quality" of the medicine is controlled, the pharmacological effect could still be inconsistent. The aim of this study is to establish an activity and absorption-based platform to select marker compound(s) for the quality control of Chinese traditional medicines. MATERIALS AND

methodsWe used ZSP as a reference Chinese traditional medicine to establish the platform. Activity guided fractionation approach was used to purify the major components from ZSP. NMR and MS spectra were used to elucidate the structure of the isolated compounds. MTT assay against oral carcinoma cell line (SCC2095) was performed to evaluate the activities. UPLC-MS/MS was used to quantify the pure compounds in ZSP and the active fraction. The permeabilities of the identified compounds were evaluated in the Caco-2 cell culture model. The intracellular accumulation of the isolated compounds was evaluated in the SCC2095 cells.

resultsThe major compounds were identified from ZSP. The contents, anti-proliferation activities, permeabilities, and intracellular accumulations of these compounds were also evaluated. The structure of these purified compounds were identified by comparing the NMR and MS data with those of references as rutaevine (1), limonin (2), evodol (3), obacunone (4), fraxinellone (5), dictamnine (6), maackiain (7), trifolirhizin (8), and matrine (9). The IC50 of compounds 5, 6, and 7 against SCC2095 cells were significantly lower than that of ZSP. The uptake permeability of compounds 5, 6, and 7 were 2.58 ± 0.3 × 10(-5), 4.33 ± 0.5 × 10(-5), and 4.27 ± 0.8 × 10(-5) respectively in the Caco-2 cell culture model. The intracellular concentrations of these compounds showed that compounds 5, 6, and 7 were significantly accumulated inside the cells.

conclusionBased on the activity against oral carcinoma cell line as well as the absorption permeability, compound 5, 6, and 7 are selected as quality control markers for ZSP. An activity and absorption-based platform was established and successfully used for the quality control of ZSP.

Indexed as

Quality ControlAlkaloidsBenzofuransBenzoxepinsCell Line, TumorCell ProliferationDrugs, Chinese HerbalGlucosidesHeterocyclic Compounds, 4 or More RingsHumansLimoninsMatrinesMedicine, Chinese TraditionalPermeabilityPhytoalexinsPterocarpansAlkaloidsAntitumor BBenzofuransBenzoxepinsdictamnineDrugs, Chinese HerbalfraxinelloneGlucosidesHeterocyclic Compounds, 4 or More RingsinerminlimoninLimoninsMatrinesobacunonePhytoalexinsPterocarpansQuinolinesQuinolizinesrutaevintrifolirhizinTriterpenesAbsorptionAnti-proliferationOral cancerQuality controlZeng-Sheng-Ping

Identifiers

PMID26099633
PMCPMC4541799
OpenAlexW974921482

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.